0.9% Sodium Chloride Injection Shortage Reported
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.9% Sodium Chloride Injection, USP has been reported. This critical medical solution is currently facing supply challenges.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, medication, 0.9%-sodium-chloride, injection.
0.9% Sodium Chloride Injection Shortage
What's in Shortage
The medication currently in shortage is 0.9% Sodium Chloride Injection, USP. This product is an injection solution used across various medical settings. The current status of this shortage is listed as Active.
Which Manufacturers Are Affected
Based on the current report (Shortage ID: 91156), specific manufacturer names, DINs, and individual availability statuses were not provided in the source data.
Why There's a Shortage
No specific reason for this shortage was provided in the source documentation at this time.
What Patients Should Do
If you are a patient or caregiver concerned about the availability of this medication, please take the following steps:
- Consult Your Healthcare Provider: Discuss your treatment plan with your doctor to understand how this shortage may impact your care.
- Speak with a Pharmacist: Pharmacists can provide information regarding local stock levels and potential supply timelines.
- Monitor Updates: Stay informed through official health agency databases for changes in supply status.
Disclaimer: Patients should always consult their healthcare provider regarding medical treatments. Do not attempt to alter or substitute medications without professional medical guidance.
Source
Information attributed to the Drug Shortages Canada database (Shortage ID: 91156).
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,416 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.